from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2722/-

LFCtreatmentdescriptionclass of inhibitor

1.180

Amikacinug/mL Amikacintranslation

0.839

Cap5-10ug/mL Capreomycintranslation

0.923

Rox10-50 ug/mL Roxithromycintranslation

0.020

SM2-5 ug/mL Streptomycintranslation

1.564

Tet5-10 ug/mL Tetracyclinetranslation

0.292

Rif0.2-5ug/mL Rifampicintranscription

-0.335

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.565

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.072

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.117

CPZ10-50 ug/mL Chlorpromazinerespiration

0.292

Clofazimine10-13 ug/mL Clofaziminerespiration

0.043

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.912

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.788

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.130

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.176

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.035

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.131

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.643

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.854

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.030

KCN5-20 ug/mL Potassium cyaniderespiration

-0.250

NaN30.2-2 mM Sodium aziderespiration

-0.489

Nigericin50 uM Nigericinrespiration

-0.858

TRC10-150 ug/mL Triclosanrespiration

-0.078

TRZ10-25 ug/mL Thioridazinerespiration

0.567

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.184

menadione6-10 ug/mL Menadionerespiration

-0.167

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.280

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.104

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.137

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.979

NRP_1Non-replicating persistence stage 1dosRassociated

0.069

Amp0.2mg/mL AmpicillincellWall

-0.232

Cephalexin20-100 ug/mL CephalexincellWall

-0.083

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.365

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.238

EMB10-20 ug/mL EthambutolcellWall

0.309

Eta12-40 ug/mL EthionamidecellWall

0.360

INH0.2-0.4 ug/mL IsoniazidcellWall

0.187

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.167

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.500

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.240

BZA0.12 mg/mL BenzamidearomaticAmides

-0.340

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.369

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.699

H2O24 mM hydrogen peroxideDNAdamaging

1.056

Levo10 ug/mL LevofloxacinDNAdamaging

0.829

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.903

Novobiocin10 ug/mL NovobiocinDNAdamaging

2.283

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.545

UVUV-irradiationDNAdamaging

-0.697

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.638

Antimycin12.5-50 ug/mL Antimycin A?

-0.161

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.105

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.846

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.850

PA8240.2-2 ug/mL PA-824?

-0.831

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.810

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.043

Verapamil50 uM Verapamil?

-0.778

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.563

methoxatin10-20 ug/mL Methoxatin?